GAMBA is a project funded in the nanotechnology call NMP-2009-2.3-1 “Biomimetic gels and polymers for tissue repair” of the EU 7th framework program.
The GAMBA consortium develops a novel gene-activated matrix platform for bone and cartilage repair with a focus on osteoarthritis-related tissue damage.
Nine consortium members from six EU countries (Member Map) team up to implement this basic research project. This contributes to the development of future therapies.
Participants Kick-off Meeting Steinebach DE (large image)